focus -WSS

focus

author：hotspot 2025-09-02 11:46:32 - browse：74148

A doctor climbs up a red ladder to a vine shaped like a DNA — biotech coverage from STAT — Adobe

Every morning, Victoria Rasberry gets up before 6 a.m., walks to the bedroom down the hall, and helps her 8-year-old daughter Addi slide into a set of contraptions that squeeze and suck out the thick mucus constantly threatening to choke her airways closed. She feeds Addi breakfast through a stomach tube and makes sure she has the right mix of the 28 different medications required to keep her free of pain, infections, and seizures. At some point, Rasberry’s five other children will wake up and start to get ready for school, including her youngest, Oliver. At 3-and-a-half years old, he’s a typical toddler — always running and giggling and getting into things. You would never know that he and Addi were born with the same mutation lurking in their DNA, a genetic glitch that causes a fatal neurodegenerative disease called metachromatic leukodystrophy, or MLD.

“When Addi was this age she had lost the ability to speak and was already using a ventilator to sleep at night,” Rasberry said. “It’s amazing to see how well Ollie is doing in comparison. And it’s all because of the gene therapy.”

Three years ago, when Ollie was just 6 months old, he and Victoria traveled from their home in Texas to Milan, to receive a gene therapy treatment that adds a healthy version of the defective gene into patients’ own stem cells. At the time, traveling abroad for the therapy, which is manufactured by Orchard Therapeutics and was approved in Europe in 2021, was the only option for families stricken by MLD. But soon it will be available in the U.S., too.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Study links childhood stress with decline in older age

Wikipedia

WSS

First medicine developed to treat MASH expected to be approved soon

How to bring more disabled researchers into academia

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Study links childhood stress with decline in older age

2 officers injured in shooting in Orlando, police say

In his State of the Union, Biden takes clear aim at 'Big Pharma'

hotspot

focus

entertainment

ChatGPT in medicine: STAT answers readers' burning questions

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Bright Health sells Medicare Advantage business to Molina

Amylyx ALS drug fails large clinical trial

Activists slam private health insurers over coverage restrictions

The drug industry has found itself all alone in Washington

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Alnylam reports growth in sales of rare disease treatments

Affirmative action in medical school literally saved lives

How to bring more disabled researchers into academia

hotspot

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Amylyx ALS drug fails large clinical trial

The a glaring gap in research on serious mental illness and primary care

FDA approves Sage Therapeutics’ rapid

Flint parents haunted by uncertainty, fears of lead poisoning

Medicare slashes safety net hospital payments by nearly $1 billion

focus

Wikipedia

Wikipedia

Wikipedia